Assessing and managing coronary microcirculation dysfunction in acute ST-segment elevation myocardial infarction

References

• Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.
   PubMed Web of Science ®Google Scholar
• Papapostolou S, Andrianopoulos N, Duffy SJ, et al. Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry. EuroIntervention. 2018;14(2):185–193.
   PubMed Web of Science ®Google Scholar
• Rezkalla H, Stankowski R, Hanna J, et al. Management of no-reflow phenomenon in the catheterization laboratory. J Invasive Cardiol. 2010;22(10 Suppl B):6B–14B.
   PubMedGoogle Scholar
• Ipek G, Onuk T, Karatas MB, et al. CHA2DS2-VASc score is a predictor of no-reflow in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous intervention. Angiology. 2016;67:840–845.
   PubMed Web of Science ®Google Scholar
• Sezer M, van Royen N, Berrin Umman B, et al. Coronary microvascular injury in reperfused acute myocardial infarction: A view from an integrative perspective. J Am Heart Assoc. 2018;7:e009949.
   PubMed Web of Science ®Google Scholar
• Kurtul A, Murat SN, Yarliogluez M, et al. Mild to moderate renal impairment is associated with no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. Angiology. 2015;66:644–651.
   PubMed Web of Science ®Google Scholar
• Magro M, Springeling T, van Geuns RJ, et al. Mycoardial ‘no-reflow’ prevention. Curr Vasc Pharmacol. 2013;11:263–277.
   PubMed Web of Science ®Google Scholar
• Sianos G, Papafaklis MI, Serruys PW. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol. 2010;22(10Suppl B):6B–14B.
   PubMedGoogle Scholar
• Niccoli G, Burzotta F, Galiuto L, et al. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54:281–292.
   PubMed Web of Science ®Google Scholar
• Morishima I, Sone T, Okumura K, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36:1202–1209.
   PubMed Web of Science ®Google Scholar
• Gibson CM, Cannon CP, Daley WL, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation. 1996;93:879–888.
   PubMed Web of Science ®Google Scholar
• Gibson CM, Cannon CP, Murphy SA, et al. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 2002;105:1909–1913.
   PubMed Web of Science ®Google Scholar
• Henriques JP, Zijlstra F, van ‘T Hof AW, et al. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 2003 Apr 29;107(16):2115–2119.
   PubMed Web of Science ®Google Scholar
• Tomasik A, Młyńczak T, Nowak E, et al. Quantitative myocardial Blush score (QuBE) allows the prediction of heart failure development in long-term follow-up in patients with ST-elevation myocardial infarction: proof of concept study. Cardiol J. 2017 Nov 13. DOI:10.5603/CJ.a2017.0129
   PubMedGoogle Scholar
• Haridasan V, Nandan D, Raju D, et al. Coronary sinus filling time: A novel method to assess microcirculatory function in patients with angina and normal coronaries. Indian Heart J. 2013 Mar;65(2):142–146.
   PubMedGoogle Scholar
• Gibson CM, Murphy SA, Rizzo MJ, et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) study group. Circulation. 1999 Apr 20;99(15):1945–1950.
   PubMed Web of Science ®Google Scholar
• Kadermuneer P, Vinod GV, Haridasan V, et al. Prognostic significance of coronary sinus filling time in patients with angina and normal coronaries at one year follow up. Indian Heart J. 2015 May-Jun;67(3):245–249.
   PubMedGoogle Scholar
• Echavarría-Pinto M, Collet C, Escaned J, et al. State of the art: pressure wire and coronary functional assessment. EuroIntervention. 2017 Aug 25;13(6):666–679.
   PubMed Web of Science ®Google Scholar
• Di Mario C, de Feyter PJ, Slager CJ, et al. Intracoronary blood flow velocity and transstenotic pressure gradient using sensor-tip pressure and Doppler guidewires: a new technology for the assessment of stenosis severity in the catheterization laboratory. Cathet Cardiovasc Diagn. 1993;28:311–319.
   PubMedGoogle Scholar
• Barbato E, Aarnoudse W, Aengevaeren WR, et al. Validation of coronary flow reserve measurements by thermodilution in clinical practice. Eur Heart J. 2004 Feb;25(3):219–223.
   PubMed Web of Science ®Google Scholar
• Pijls NH, De Bruyne B, Smith L, et al. Coronary thermodilution to assess flow reserve: validation in humans. Circulation. 2002 May 28;105(21):2482–2486.
   PubMed Web of Science ®Google Scholar
• Yew SN, Carrick D, Corcoran D, et al. Coronary thermodilution waveforms after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognosis. J Am Heart Assoc. 2018 Aug 7;7(15):e008957.
   PubMed Web of Science ®Google Scholar
• De Maria GL, Cuculi F, Patel N, et al. How does coronary stent implantation impact on the status of the microcirculation during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction? Eur Heart J. 2015 Dec 1;36(45):3165–3177.
   PubMed Web of Science ®Google Scholar
• Patel N, Petraco R, Dall’Armellina E, et al. Zero-flow pressure measured immediately after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction provides the best invasive index for predicting the extent of myocardial infarction at 6 months: an OxAMI Study (Oxford Acute Myocardial Infarction). JACC Cardiovasc Interv. 2015 Sep;8(11):1410–1421.
   PubMed Web of Science ®Google Scholar
• Hirsch A, Nijveldt R, Haeck JD, et al. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. J Am Coll Cardiol. 2008 Jun 10;51(23):2230–2238.
   PubMed Web of Science ®Google Scholar
• Yong AS, Layland J, Fearon WF, et al. Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC Cardiovasc Interv. 2013;6(1):53–58.
   PubMed Web of Science ®Google Scholar
• Yong AS, Ho M, Shah MG, et al. Coronary microcirculatory resistance is independent of epicardial stenosis. Circ Cardiovasc Interv. 2012;5(1):103–108, S1–S2.
   Web of Science ®Google Scholar
• Williams RP, de Waard GA, De Silva K, et al. Doppler versus thermodilution-derived coronary microvascular resistance to predict coronary microvascular dysfunction in patients with acute myocardial infarction or stable angina pectoris. Am J Cardiol. 2018 Jan 1;121(1):1–8.
   PubMed Web of Science ®Google Scholar
• Fearon WF, Low AF, Yong AS, et al. Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention. Circulation. 2013 Jun 18;127(24):2436–2441.
   PubMed Web of Science ®Google Scholar
• Bulluck H, Foin N, Cabrera-Fuentes HA, et al. Index of microvascular resistance and microvascular obstruction in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2016 Oct 24;9(20):2172–2174.
   PubMed Web of Science ®Google Scholar
• Carrick D, Haig C, Ahmed N, et al. Comparative prognostic utility of indexes of microvascular function alone or in combination in patients with an acute ST-segment-elevation myocardial infarction. Circulation. 2016;134(23):1833–1847.
   PubMed Web of Science ®Google Scholar
• Carrick D, Haig C, Carberry J, et al. Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction. JCI Insight. 2016;1(6):e85768.
   PubMed Web of Science ®Google Scholar
• de Waard GA, Fahrni G, de Wit D, et al. Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction. Heart. 2018 Jan;104(2):127–134.
   PubMed Web of Science ®Google Scholar
• Xaplanteris P, Fournier S, Keulards DCJ. Catheter-based measurements of absolute coronary blood flow and microvascular resistance: feasibility, safety, and reproducibility in humans. Circ Cardiovasc Interv. 2018 Mar;11(3):e006194.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Kharbanda RK, Crea F, et al. No-reflow: again prevention is better than treatment. Eur Heart J. 2010 Oct;31(20):2449–2455.
   PubMed Web of Science ®Google Scholar
• Amit G, Cafri C, Yaroslavtsev S, et al. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial. Am Heart J. 2006 Nov;152(5):887.e9–e14.
   PubMed Web of Science ®Google Scholar
• Nazir SA, McCann GP, Greenwood JP, et al. Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial. Eur Heart J. 2016 Jun 21;37(24):1910–1919.
   PubMed Web of Science ®Google Scholar
• Kumbhani DJ, de Lemos JA. Finding an effective treatment for microvascular obstruction in STEMI: a road to perdition? Eur Heart J. 2016 Jun 21;37(24):1920–1922.
   PubMed Web of Science ®Google Scholar
• Vijayalakshmi K, Whittaker VJ, Kunadian B, et al. Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. Heart. 2006 Sep;92(9):1278–1284.
   PubMed Web of Science ®Google Scholar
• Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation. 2000 May 9;101(18):2154–2159.
   PubMed Web of Science ®Google Scholar
• Mahaffey KW, Puma JA, Barbagelata NA, et al. Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of Adenosine (AMISTAD) trial. J Am Coll Cardiol. 1999;34:1711–1720.
   PubMed Web of Science ®Google Scholar
• Ross AM, Gibbons RJ, Stone GW, et al. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005;45:1775–1780.
   PubMed Web of Science ®Google Scholar
• Taniyama Y, Ito H, Iwakura K, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial salvage in patients with acute myocardial infarction. J Am Coll Cardiol. 1997 Nov 1;30(5):1193–1199.
   PubMed Web of Science ®Google Scholar
• Ishii H, Ichimiya S, Kanashiro M, et al. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction. Circulation. 2005 Aug 30;112(9):1284–1288.
   PubMed Web of Science ®Google Scholar
• Kostic J, Djordjevic-Dikic A, Dobric M, et al. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI. Cardiovasc Ultrasound. 2015 May;27(13):26.
   Google Scholar
• Kikuchi Y, Takahashi J, Sato K, et al. Usefulness and safety of fasudil, a selective Rho-kinase inhibitor, for PCI-related myocardial ischemia in interventional cardiology. Eur Heart J. 2018;39(Supplement):136.
   Google Scholar
• Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012 May 2;307(17):1817–1826.
   PubMed Web of Science ®Google Scholar
• Bellandi F, Maioli M, Gallopin M, et al. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention. Catheter Cardiovasc Interv. 2004 Jun;62(2):186–192.
   PubMed Web of Science ®Google Scholar
• Thiele H, Wöhrle J, Hambrecht R, et al. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet. 2012 Mar 10;379(9819):923–931.
   PubMed Web of Science ®Google Scholar
• Bainey KR, Welsh RC, Mehta S. Meta-analysis of intracoronary thrombolytic as an adjunct to primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Can J Cardiol. 2015 Oct;31(10):1. (Supplement).
   PubMedGoogle Scholar
• Berry C. Trial of low-dose adjunctive alteplase during primary PCI - T-TIME. Conference of the American Heart Association; 2018 Nov 10–12; Chicago, USA.
   Google Scholar
• Werner GS, Lang K, Kuehnert H. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv. 2002 Dec;57(4):444–451.
   PubMed Web of Science ®Google Scholar
• Kobatake R, Sato T, Fujiwara Y, et al. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction. Heart Vessels. 2011 Jul;26(4):379–384.
   PubMed Web of Science ®Google Scholar
• Rezkalla SH, Dharmashankar KC, Abdalrahman IB, et al. No-reflow phenomenon following percutaneous coronary intervention for acute myocardial infarction: incidence, outcome, and effect of pharmacologic therapy. J Interv Cardiol. 2010 Oct;23(5):429–436.
   PubMed Web of Science ®Google Scholar
• Airoldi F, Briguori C, Cianflone D, et al. Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside. Am J Cardiol. 2007 Apr 1;99(7):916–920.
   PubMed Web of Science ®Google Scholar
• Ono H, Osanai T, Ishizaka H, et al. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation. Am Heart J. 2004 Oct;148(4):E15.
   PubMed Web of Science ®Google Scholar
• Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol. 1999 Mar;33(3):654–660.
   PubMed Web of Science ®Google Scholar
• Kitakaze M, Asakura M, Kim J, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007 Oct 27;370(9597):1483–1493.
   PubMed Web of Science ®Google Scholar
• Skelding KA, Goldstein JA, Mehta L, et al. Resolution of refractory no-reflow with intracoronary epinephrine. Catheter Cardiovasc Interv. 2002 Nov;57(3):305–309.
   PubMed Web of Science ®Google Scholar
• Aksu T, Guler TE, Colak A, et al. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord. 2015 Feb;19(15):10.
   Google Scholar
• Rawitscher D, Levin TN, Cohen I, et al. Rapid reversal of no-reflow using Abciximab after coronary device intervention. Cathet Cardiovasc Diagn. 1997 Oct;42(2):187–190.
   PubMedGoogle Scholar
• Boscarelli D, Vaquerizo B, Miranda-Guardiola F, et al. Intracoronary thrombolysis in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration. Eur Heart J Acute Cardiovasc Care. 2014 Sep;3(3):229–236.
   PubMedGoogle Scholar
• Bøtker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet. 2010 Feb 27;375(9716):727–734.
   PubMed Web of Science ®Google Scholar
• Loubeyre C, Morice MC, Lefèvre T, et al. randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J Am Coll Cardiol. 2002 Jan 2;39(1):15–21.
   PubMed Web of Science ®Google Scholar
• Cuellas C, Fernández-Vázquez F, Martínez G, et al. Direct stent implantation in acute myocardial infarction. Rev Esp Cardiol. 2006 Mar;59(3):217–224. Spanish.
   PubMed Web of Science ®Google Scholar
• Gasior M, Gierlotka M, Lekston A, et al. Comparison of outcomes of direct stenting versus stenting after balloon predilation in patients with acute myocardial infarction (DIRAMI). Am J Cardiol. 2007 Sep 1;100(5):798–805.
   PubMed Web of Science ®Google Scholar
• Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med. 2008 Feb 7;358(6):557–567.
   PubMed Web of Science ®Google Scholar
• Fröbert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013 Oct 24;369(17):1587–1597.
   PubMed Web of Science ®Google Scholar
• Jolly SS, Cairns JA, Yusuf S, et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med. 2015 Apr 9;372(15):1389–1398.
   PubMed Web of Science ®Google Scholar
• Jolly S, James S, Džavík V, et al. Thrombus aspiration in ST-segment-elevation myocardial infarction: an individual patient meta-analysis: thrombectomy trialists collaboration. Circulation. 2017 Jan 10;135(2):143–152.
   PubMed Web of Science ®Google Scholar
• Carrick D, Oldroyd KG, McEntegart M, et al. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI). J Am Coll Cardiol. 2014 May 27;63(20):2088–2098.
   PubMed Web of Science ®Google Scholar
• Kelbæk H, Høfsten DE, Køber L, et al. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial. Lancet. 2016 May 28;387(10034):2199–2206.
   PubMed Web of Science ®Google Scholar
• De Maria GL, Alkhalil M, Oikonomou EK, et al. Role of deferred stenting in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention: A systematic review and meta-analysis. J Interv Cardiol. 2017 Jun;30(3):264–273.
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Marroquin OC, Stone RA, et al. Differential effects of post-dilation after stent deployment in patients presenting with and without acute myocardial infarction. Am Heart J. 2010 Nov;160(5):979–986.e1.
   PubMed Web of Science ®Google Scholar
• Stone GW, Abizaid A, Silber S, et al. Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (mguard) in ST-segment elevation myocardial infarction: the master trial. J Am Coll Cardiol. 2012 Nov 6;60(19):1975–1984.
   PubMed Web of Science ®Google Scholar
• Dahm JB, Ebersole D, Das T, et al. Prevention of distal embolization and no-reflow in patients with acute myocardial infarction and total occlusion in the infarct-related vessel: a subgroup analysis of the cohort of acute revascularization in myocardial infarction with excimer laser-CARMEL multicenter study. Catheter Cardiovasc Interv. 2005 Jan;64(1):67–74.
   PubMed Web of Science ®Google Scholar
• Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002 Mar 19;105(11):1285–1290.
   PubMed Web of Science ®Google Scholar
• Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005 Mar 2;293(9):1063–1072.
   PubMed Web of Science ®Google Scholar
• De Maria GL, Alkhalil M, Borlotti A, et al. Index of microcirculatory resistance-guided therapy with pressure-controlled intermittent coronary sinus occlusion improves coronary microvascular function and reduces infarct size in patients with ST-elevation myocardial infarction: the oxford acute myocardial infarction - pressure-controlled intermittent coronary sinus occlusion study (OxAMI-PICSO study). EuroIntervention. 2018 Jun 8;14(3):e352–e359.
   PubMed Web of Science ®Google Scholar
• Schwartz J, Hoem J, Schwartz J, et al. Dynamic absolute microvascular function assessment: resistance and compliance in real time by controlled flow infusion. Presented at: EuroPCR; 2018 May 23; Paris, France.
   Google Scholar
• Pellegrini G, Cesarovic N, Gastl M, et al. ST-elevation myocardial infarction-derived coronary microvascular obstruction is NOT thrombus dependent: results from a porcine coronary model. Presented at: The 67th Annual Conference of the American College of Cardiology; 2018 Mar 10–12; Orlando, Florida.
   Google Scholar
• Schwartz RS, Hoem JH, Bludau O, et al. Controlled coronary flow infusion measures dynamic myocardial microvascular resistance in real time during experimental STEMI. Presented at: The 67th Annual Conference of the American College of Cardiology; 2018 Mar 10–12; Orlando, Florida.
   Google Scholar
• Fahrni G, Wolfrum M, De Maria GL, et al. Index of microcirculatory resistance at the time of primary percutaneous coronary intervention predicts early cardiac complications: insights from the OxAMI (Oxford Study in Acute Myocardial Infarction) Cohort. J Am Heart Assoc. 2017 Nov 7;6(11).
   PubMed Web of Science ®Google Scholar
• De Maria GL, Alkhalil M, Wolfrum M, et al. The ATI score (age-thrombus burden-index of microcirculatory resistance) determined during primary percutaneous coronary intervention predicts final infarct size in patients with ST-elevation myocardial infarction: a cardiac magnetic resonance validation study. EuroIntervention. 2017 Oct 20;13(8):935–943.
   PubMed Web of Science ®Google Scholar
• Bulluck H, Foin N, Tan JW, et al. Invasive assessment of the coronary microcirculation in reperfused ST-segment-elevation myocardial infarction patients: where do we stand? Circ Cardiovasc Interv. 2017 Mar;10(3).
   PubMed Web of Science ®Google Scholar